根据调整的发病率组,根据多药患者的风险水平,医疗保健服务利用率的差异:基于人口的横截面研究
Jaime Barrio-Cortes1,2,3,4, Beatriz Benito-Sánchez5, Ana Isabel Villimar-Rodriguez6
1Foundation for Biosanitary Research and Innovation in Primary Care (FIIBAP), Ave. Reina Victoria, 21, 6Th Floor, 28003, Madrid, Spain.
Journal of pharmaceutical policy and practice
|November 29, 2023
概括
被定义为使用多种药物的多药症患者表现出更高的医疗保健利用率. 这项研究突出了他们的复杂需求,为更好的管理和降低成本提供了资源分配的信息.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
背景情况:
- 多药店由于复杂的医疗状况而造成了严重的医疗负担.
- 了解多药店对初级保健 (PC) 和医院护理 (HC) 的影响至关重要.
研究的目的:
- 为了表征慢性患者的多药性.
- 分析多药店患者的医疗保健利用模式.
- 将多药房患者与非多药房患者进行比较.
主要方法:
- 在西班牙医疗保健领域使用电子健康记录进行横截面研究.
- 利用调整的发病率组 (AMG) 工具来识别慢性疾病.
- 分析了社会人口统计,临床和医疗保健利用数据,并对相关因素进行回归建模.
主要成果:
- 多药房患者年龄较大 (平均年龄为82.7岁与52.7岁),主要是女性 (68.9%),风险较高 (22.0%).
- 他们患有更多的慢性疾病 (4.8 vs 2.2) 和多重疾病 (95.6% vs 56.9%).
- 医疗保健接触人数显著增加 (每年30.3人与10.5人),PC和HC利用率增加.
结论:
- 多药性与年龄较大,女性性别,高风险,复杂性,多病态性和医疗保健利用率更高有关.
- 结果支持优化PC和HC的资源配置,以改善多药房管理.
- 策略可以提高合理的药物使用,并降低医疗保健成本.
相关概念视频
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
Traditional Level Of Health Care System
2.8K
The levels of care describe the services provided in the healthcare system. Accordingly, there are six levels of the traditional healthcare system in the US: preventive, primary, secondary, tertiary, restorative, and continuing healthcare. A nurse must understand how the healthcare industry organizes and provides services within these levels of care.
The preventive healthcare service includes tests for screening. Preventive health care services include identifying and reducing disease risk...
The preventive healthcare service includes tests for screening. Preventive health care services include identifying and reducing disease risk...
2.8K
Methods of Documentation VI: Case Management Model
574
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
574
Analysis of Population Pharmacokinetic Data
266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
Hazard Ratio
130
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
130


